Advanced Therapy Medicinal Products (ATMP) CDMO Market Size, Share, Trends 2025–2034

The global advanced therapy medicinal products (ATMP) contract development and manufacturing organization (CDMO) market was valued at USD 7.08 billion in 2024, propelled by the surge in clinical trials for ATMPs across the globe. The market is projected to expand at a CAGR of 15.30% during 2025–2034, reaching a value of approximately USD 29.40 billion by 2034. This growth is attributed to rising demand for gene therapies, cell therapies, and tissue-engineered products, alongside increased outsourcing by biopharmaceutical companies to CDMOs for ATMP development and manufacturing.